pDONR221-SARS-CoV-2-nsp4-nsp5-C145A-nsp6
(Plasmid
#247700)
-
PurposeGateway compatible entry vector of SARS-CoV-2 nsp4 fused to nsp5 with a C145A mutation fused to the N-terminus of nsp6.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 247700 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepDONR221
-
Vector typeSynthetic Biology
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSARS-CoV-2 3CL protease with C145A fused to nsp4 and nsp6
-
SpeciesSARS-CoV-2
-
MutationC145A
Cloning Information
- Cloning method Gateway Cloning
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pDONR221-SARS-CoV-2-nsp4-nsp5-C145A-nsp6 was a gift from Sho Iketani (Addgene plasmid # 247700 ; http://n2t.net/addgene:247700 ; RRID:Addgene_247700) -
For your References section:
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors. Chithelen J, Lovett DH, Wang K, Torres Yanagisawa AE, Caccin FNM, Iketani S. Nat Commun. 2026 May 19;17(1):6575. doi: 10.1038/s41467-026-73444-y. 10.1038/s41467-026-73444-y PubMed 42156379